C12N 2760/12143
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2760/12143 (Viral genome or elements thereof as genetic vector) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 4
- Assignees
- 5
- Inventors
- 1
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
By publication year.
Recent patents
- Sin Nombre virus full-length M segment-based DNA vaccines26 Oct 2021US 11,155,834 B2The Government of the United States, as represented by the Secretary of the Army
- Sin Nombre virus full-length M segment-based DNA vaccines15 Oct 2019US 10,443,073 B2The Government of the United States, as represented by the Secretary of the Army
- Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene19 Apr 2016US 9,315,826 B2The United States of America as rep. by the Sec'y of the Army, for U.S. Army Medical Research Institute of Infectious Diseases
- Sin nombre virus full-length m segment-based dna vaccines24 Mar 2022US 2022/0090136 A1The Government of the United States, as represented by the Secretary of the Army
- Sin nombre virus full-length m segment-based dna vaccines2 Apr 2020US 2020/0102576 A1The Government of the United States, as represented by the Secretary of the Army
- Sin nombre virus full-length m segment-based dna vaccines1 Dec 2016US 2016/0346376 A1The United States of America, as rep. by the Sec'y of the Army, for U.S. Army Medical Research Insti
- Sin Nombre Virus Full-Length M Segment-Based DNA Vaccines20 Mar 2014US 2014/0079731 A1The United States of America as rep. by the Sec'y the army for U.S. Army Medical Research Institute
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.